Geisinger Health System is, in practice, what most people conceptualize as an Accountable Care Organization. Our unique structure includes the entire continuum of care on the provider’s side, plus an insurance company. We have significant market share in both the provider and the insurance markets, and a very stable demography for our patient and beneficiary populations. Most importantly, the Geisinger culture has developed over almost one hundred years into one truly functional integration. All of this (plus 15 years of systemwide EHR) has enabled an almost perfect “test-bed” to fundamentally re-engineer care. The major rationale for such fundamental change in how we care for hospitalized patients as well as the highest cost multiple chronic disease cohort is a realization that much of what we do and what we pay for in healthcare adds no value to the people we serve. Glenn will report on five categories of Geisinger innovation, discuss the utility of rapid cycle iterative change in our reengineering experimental model, and discuss major challenges in our attempt to scale and generalize quality and value benefits into more complex markets.
What are the critical functions of ACOs?
How can leadership accomplish continuing clinical innovation?
Categories and examples of fundamental re-engineered care